Anne Nagengast Johnson - Mar 14, 2025 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role: Chief Financial Officer
Signature: /s/ Ryan Barrett, Attorney-in-fact
Stock symbol: ATAI
Transactions as of: Mar 14, 2025
Transactions value $: $0
Form type: 4
Date filed: 3/19/2025, 07:29 PM
Previous filing: Mar 5, 2025
Next filing: Mar 24, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATAI	Common Shares	Options Exercise		+100K	+135.89%		174K	Mar 14, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATAI	Restricted Stock Units	Options Exercise	$0	-100K	-100%	$0.00	0	Mar 14, 2025	Common Shares	100K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units vested on March 14, 2024, the first anniversary of the grant date and 50% vested on March 14, 2025, the second anniversary of the grant date.